Nasdaq
$0.3563▼ 1.68%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.8MShares out 10.7M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
3- 10.16After-hours26.10.17 06:008-KKey event#●●●
PharmaCyte Biotech, Inc.
PharmaCyte Biotech dismissed its independent registered public accounting firm, CBIZ CPAs P.C., and appointed Grassi & Co., CPAs, P.C. as its new auditor, effective October 14, 2026. The company reported no disagreements with the former auditor regarding accounting principles or auditing scope.…more
$0.3563-1.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.14After-hours26.09.15 05:0510-QEarnings
PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. has filed its Form 10-Q quarterly report for the first quarter of fiscal year 2027, which ended on July 31, 2026. As of September 11, 2026, the company had 10,735,649 shares of common stock outstanding.…more
$0.3563-1.68%vs prev closeView filingShare - 7.29After-hours26.07.30 05:5810-KEarnings
PharmaCyte Biotech, Inc.
파마사이트 바이오텍(PharmaCyte Biotech, Inc.)은 2026년 4월 30일 종료된 회계연도에 대한 10-K 연례 보고서를 제출했습니다. 해당 공시는 회사의 재무 상태와 운영 결과에 대한 경영진의 인증을 포함하고 있으며, 정관 개정 및 자회사 목록을 명시하고 있습니다.…more
$0.3563-1.68%vs prev closeView filingShare
2 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.14After-hours26.09.15 06:03#●●●#●●●
PharmaCyte Biotech Reports Q1 EPS of $(0.54)
PharmaCyte Biotech reported a quarterly loss of $0.54 per share, showing an improvement from the $1.23 loss in the same period last year. However, the company recorded $0.00 in sales, remaining unchanged from the previous year.…more
$0.3563-1.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga